ScripThe uncertainty created by potential tariffs and US healthcare strategies has seen some senior pharma figures express concern about the impact on M&A but GSK CEO Emma Walmsley is confident that de
Pink SheetThe US Food and Drug Administration’s prescription drug user fee goal date calendar for May may be overshadowed by the 31 May goal date for Moderna ’s next-generation COVID-19 vaccine, given a resurg
ScripGSK’s Blenrep’s initial regulatory approval as a treatment for second-line relapsed/refractory multiple myeloma, marks just the first big step in what could be a remarkable comeback for the antibody-d
In VivoQuin Wills, an Oxford and Cambridge University alumnus with a DPhil in Statistical Genomics, MSc in Applied and Computational Mathematics, and MPhil in Computational Biology, co-founded Ochre Bio afte